HRP20171514T1 - Derivati indolouree supstituirani glukopiranozilom i njihova upotreba kao inhibitora sglt - Google Patents
Derivati indolouree supstituirani glukopiranozilom i njihova upotreba kao inhibitora sglt Download PDFInfo
- Publication number
- HRP20171514T1 HRP20171514T1 HRP20171514TT HRP20171514T HRP20171514T1 HR P20171514 T1 HRP20171514 T1 HR P20171514T1 HR P20171514T T HRP20171514T T HR P20171514TT HR P20171514 T HRP20171514 T HR P20171514T HR P20171514 T1 HRP20171514 T1 HR P20171514T1
- Authority
- HR
- Croatia
- Prior art keywords
- glucopyranosyl
- compound
- urea derivatives
- substituted indole
- salt
- Prior art date
Links
- WCXSCSQEEQHANA-UHFFFAOYSA-N 1h-indole;urea Chemical class NC(N)=O.C1=CC=C2NC=CC2=C1 WCXSCSQEEQHANA-UHFFFAOYSA-N 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 6
- 206010012601 diabetes mellitus Diseases 0.000 claims 3
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
- 239000002585 base Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/044—Pyrrole radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (7)
1. Spoj, naznačen time što ima formulu:
[image]
,
ili njegova farmaceutski prihvatljiva sol.
2. Spoj u skladu s patentnim zahtjevom 1, naznačen time što je:
[image]
.
3. Spoj, ili sol, u skladu s bilo patentnim zahtjevom 1 ili patentnim zahtjevom 2, naznačen time što je namijenjen upotrebi u terapiji.
4. Spoj, ili sol, u skladu s bilo patentnim zahtjevom 1 ili patentnim zahtjevom 2, naznačen time što je namijenjen upotrebi u liječenju dijabetesa.
5. Spoj, ili sol, namijenjen upotrebi u skladu s patentnim zahtjevom 4, naznačen time što je dijabetes dijabetes tip 1.
6. Spoj, ili sol, namijenjen upotrebi u skladu s patentnim zahtjevom 4, naznačen time što je dijabetes dijabetes tip 2.
7. Farmaceutski pripravak, naznačen time što sadrži spoj, ili sol, u skladu s bilo patentnim zahtjevom 1 ili patentnim zahtjevom 2, uz jednu ili više farmaceutski prihvatljivih podloga, razrjeđivača ili pomoćnih tvari.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361898494P | 2013-11-01 | 2013-11-01 | |
| PCT/US2014/062548 WO2015065956A1 (en) | 2013-11-01 | 2014-10-28 | Glucopyranosyl-substituted indole-urea derivatives and their use as sglt inhibitors |
| EP14793753.6A EP3063162B1 (en) | 2013-11-01 | 2014-10-28 | Glucopyranosyl-substituted indole-urea derivatives and their use as sglt inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20171514T1 true HRP20171514T1 (hr) | 2017-11-17 |
Family
ID=51862614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20171514TT HRP20171514T1 (hr) | 2013-11-01 | 2017-10-09 | Derivati indolouree supstituirani glukopiranozilom i njihova upotreba kao inhibitora sglt |
Country Status (39)
| Country | Link |
|---|---|
| US (1) | US9145437B2 (hr) |
| EP (1) | EP3063162B1 (hr) |
| JP (1) | JP6147429B2 (hr) |
| KR (1) | KR101838826B1 (hr) |
| CN (1) | CN105636972B (hr) |
| AP (1) | AP2016009137A0 (hr) |
| AR (1) | AR098134A1 (hr) |
| AU (1) | AU2014342612B2 (hr) |
| BR (1) | BR112016008704B1 (hr) |
| CA (1) | CA2924516C (hr) |
| CL (1) | CL2016000988A1 (hr) |
| CR (1) | CR20160146A (hr) |
| CY (1) | CY1119540T1 (hr) |
| DK (1) | DK3063162T3 (hr) |
| DO (1) | DOP2016000062A (hr) |
| EA (1) | EA029516B1 (hr) |
| ES (1) | ES2646125T3 (hr) |
| HK (1) | HK1222661A1 (hr) |
| HR (1) | HRP20171514T1 (hr) |
| HU (1) | HUE034689T2 (hr) |
| IL (1) | IL244896B (hr) |
| JO (1) | JO3298B1 (hr) |
| LT (1) | LT3063162T (hr) |
| MA (1) | MA38991B1 (hr) |
| ME (1) | ME02839B (hr) |
| MX (1) | MX2016005428A (hr) |
| NO (1) | NO3099623T3 (hr) |
| NZ (1) | NZ717880A (hr) |
| PE (1) | PE20160663A1 (hr) |
| PH (1) | PH12016500809A1 (hr) |
| PL (1) | PL3063162T3 (hr) |
| PT (1) | PT3063162T (hr) |
| RS (1) | RS56417B1 (hr) |
| SG (1) | SG11201602950UA (hr) |
| SI (1) | SI3063162T1 (hr) |
| TN (1) | TN2016000125A1 (hr) |
| TW (1) | TWI657093B (hr) |
| UA (1) | UA117137C2 (hr) |
| WO (1) | WO2015065956A1 (hr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110128493B (zh) * | 2018-02-08 | 2021-01-12 | 亚宝药业集团股份有限公司 | 吡喃糖取代杂环化合物的盐及其制备方法和用途 |
| WO2024055932A1 (zh) * | 2022-09-13 | 2024-03-21 | 亚宝药业集团股份有限公司 | 氮杂环化合物、其药物组合物和用于预防和/或治疗疾病的用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA200501094B (en) * | 2002-08-08 | 2006-10-25 | Kissei Pharmaceutical | Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| ZA200501549B (en) * | 2002-08-23 | 2006-07-26 | Kissei Pharmaceutical | Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof and intermediate for the production thereof |
| JP5046370B2 (ja) * | 2004-09-29 | 2012-10-10 | キッセイ薬品工業株式会社 | １−（β−Ｄ−グリコピラノシル）−３−置換含窒素ヘテロ環化合物、それを含有する医薬組成物及びその医薬用途 |
| WO2006054629A1 (ja) | 2004-11-18 | 2006-05-26 | Kissei Pharmaceutical Co., Ltd. | １－置換－３－（β－Ｄ－グリコピラノシル）含窒素ヘテロ環化合物、及びそれを含有する医薬 |
| TWI418556B (zh) * | 2006-07-27 | 2013-12-11 | Mitsubishi Tanabe Pharma Corp | 吲哚衍生物 |
| UA113086C2 (xx) | 2012-05-10 | 2016-12-12 | Піразольні сполуки як інгібітори sglt1 | |
| TW201425326A (zh) * | 2012-10-05 | 2014-07-01 | Lilly Co Eli | 新穎脲化合物 |
-
2014
- 2014-10-21 AR ARP140103946A patent/AR098134A1/es active IP Right Grant
- 2014-10-21 JO JOP/2014/0303A patent/JO3298B1/ar active
- 2014-10-22 TW TW103136540A patent/TWI657093B/zh active
- 2014-10-28 MA MA38991A patent/MA38991B1/fr unknown
- 2014-10-28 EA EA201690593A patent/EA029516B1/ru not_active IP Right Cessation
- 2014-10-28 DK DK14793753.6T patent/DK3063162T3/en active
- 2014-10-28 TN TN2016000125A patent/TN2016000125A1/en unknown
- 2014-10-28 AP AP2016009137A patent/AP2016009137A0/en unknown
- 2014-10-28 CA CA2924516A patent/CA2924516C/en active Active
- 2014-10-28 CN CN201480054233.8A patent/CN105636972B/zh active Active
- 2014-10-28 MX MX2016005428A patent/MX2016005428A/es active IP Right Grant
- 2014-10-28 JP JP2016526803A patent/JP6147429B2/ja active Active
- 2014-10-28 PE PE2016000528A patent/PE20160663A1/es active IP Right Grant
- 2014-10-28 US US14/525,237 patent/US9145437B2/en active Active
- 2014-10-28 WO PCT/US2014/062548 patent/WO2015065956A1/en active Application Filing
- 2014-10-28 UA UAA201603793A patent/UA117137C2/uk unknown
- 2014-10-28 EP EP14793753.6A patent/EP3063162B1/en active Active
- 2014-10-28 LT LTEP14793753.6T patent/LT3063162T/lt unknown
- 2014-10-28 KR KR1020167011064A patent/KR101838826B1/ko active IP Right Grant
- 2014-10-28 HU HUE14793753A patent/HUE034689T2/hu unknown
- 2014-10-28 SG SG11201602950UA patent/SG11201602950UA/en unknown
- 2014-10-28 RS RS20170972A patent/RS56417B1/sr unknown
- 2014-10-28 SI SI201430344T patent/SI3063162T1/sl unknown
- 2014-10-28 AU AU2014342612A patent/AU2014342612B2/en active Active
- 2014-10-28 BR BR112016008704-6A patent/BR112016008704B1/pt active IP Right Grant
- 2014-10-28 NZ NZ717880A patent/NZ717880A/en unknown
- 2014-10-28 PL PL14793753T patent/PL3063162T3/pl unknown
- 2014-10-28 ES ES14793753.6T patent/ES2646125T3/es active Active
- 2014-10-28 ME MEP-2017-222A patent/ME02839B/me unknown
- 2014-10-28 PT PT147937536T patent/PT3063162T/pt unknown
-
2015
- 2015-01-19 NO NO15700693A patent/NO3099623T3/no unknown
-
2016
- 2016-03-11 DO DO2016000062A patent/DOP2016000062A/es unknown
- 2016-03-31 CR CR20160146A patent/CR20160146A/es unknown
- 2016-04-04 IL IL244896A patent/IL244896B/en active IP Right Grant
- 2016-04-26 CL CL2016000988A patent/CL2016000988A1/es unknown
- 2016-04-29 PH PH12016500809A patent/PH12016500809A1/en unknown
- 2016-09-08 HK HK16110670.8A patent/HK1222661A1/zh unknown
-
2017
- 2017-10-09 HR HRP20171514TT patent/HRP20171514T1/hr unknown
- 2017-10-10 CY CY20171101047T patent/CY1119540T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20171512T1 (hr) | Derivati betulina | |
| HRP20171648T1 (hr) | Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze | |
| HRP20210212T1 (hr) | Triciklični spoj kao antikancerogeni agensi | |
| HRP20180591T1 (hr) | Inhibitori kinaze serina ili treonina | |
| HRP20192202T1 (hr) | Acc inhibitori i njihove upotrebe | |
| HRP20191523T1 (hr) | Paraziticidne kombinacije spirocikličkog izoksazolina | |
| HRP20210529T1 (hr) | Inhibitori za mk2 i njihove uporabe | |
| EA201592250A1 (ru) | Пиразолопирролидиновые производные и их применение в лечение заболеваний | |
| BR112017025108A2 (pt) | compostos seletivos de pyy e usos dos mesmos | |
| HRP20240168T1 (hr) | Kombinacije dolutegravira i lamivudina za liječenje hiv infekcije | |
| CA2894892A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
| PH12015501993B1 (en) | Pyrazole-amide compound and medicinal uses therefor | |
| RS54873B1 (sr) | Policiklična-karbamoilpiridonska jedinjenja i njihova farmaceutska upotreba | |
| EA201690287A1 (ru) | 1,4-дизамещенные аналоги пиридазин хинолина и способы лечения состояний, связанных с smn-дефицитом | |
| EA201692443A1 (ru) | Водная фармацевтическая композиция тапентадола для перорального введения | |
| IL295418B1 (en) | Beta-d-2'-deoxy-2' alpha-fluoro-2'-bata-c-modified-2-different-n6-purine modified nucleotides for the treatment of hepatitis c virus | |
| BR112014005407A2 (pt) | composto, composição farmacêutico, uso do composto ou um sal farmaceuticamente aceitável do mesmo, e, método de tratamento de um paciente infectado com hcv | |
| IL240949B (en) | Aqueous pharmaceutical formulation for use in the treatment of type 1 or type 2 juvenile diabetes | |
| NZ720328A (en) | Pyranochromenyl phenol derivative, and pharmaceutical composition for treating metabolic syndrome or inflammatory disease | |
| EA201691918A1 (ru) | Фармацевтические составы ингибитора киназ семейства raf, способы их получения и способы их применения | |
| EA201691490A1 (ru) | Фармацевтическая композиция, содержащая бринзоламид | |
| FI3666258T3 (fi) | Menetelmä prader-willin oireyhtymän hoitamiseksi | |
| UY35771A (es) | Tienouracil-carboxamidas cíclicas y su uso | |
| HRP20201187T1 (hr) | Derivat triazolopirazinona koristan kao inhibitor ljudskog pde1 | |
| CA2922375C (en) | Alpha-tea salt forms: compositions and uses for treating disease |